Patents by Inventor Marc Guell

Marc Guell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11987788
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Grant
    Filed: August 28, 2020
    Date of Patent: May 21, 2024
    Assignee: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20240052371
    Abstract: The present disclosure provides efficient and precise programmable gene delivery technology based on a composition comprising (i) a first protein comprising or consisting of a site-specific DNA binding protein capable of binding and cleaving a target nucleic acid sequence; or a nucleic acid construct encoding said first protein; and (ii) a second protein comprising or consisting of a transposase; or a nucleic acid construct encoding said second protein; wherein said transposase is a modified hyperactive PiggyBac.
    Type: Application
    Filed: December 16, 2021
    Publication date: February 15, 2024
    Applicant: UNIVERSITAT POMPEU FABRA
    Inventors: Marc GUELL CARGOL, Avencia SANCHEZ-MEJIAS GARCIA, Maria PALLARES MASMITJA, Dimitrie IVANCIC DJERMANOVIC, Amal RAHMEH
  • Publication number: 20230056661
    Abstract: Described here are methods, compositions, and systems for generating transgenic islet cells suitable for xenotransplantation.
    Type: Application
    Filed: January 7, 2021
    Publication date: February 23, 2023
    Inventors: Yangbin GAO, Yanan YUE, Luhan YANG, Marc GUELL, Yinan KAN, Wenning QIN
  • Patent number: 11541081
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Grant
    Filed: October 19, 2017
    Date of Patent: January 3, 2023
    Assignee: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20220267805
    Abstract: Provided are cells, tissues, organs, and/or animals having one or more modified genes for enhanced xenograft survival and/or tolerance. And methods of producing and using the cells, tissues, organs, and/or animals.
    Type: Application
    Filed: May 15, 2020
    Publication date: August 25, 2022
    Inventors: Luhan YANG, Yangbin GAO, Marc GUELL, Yinan KAN, Wenning QIN
  • Publication number: 20220235379
    Abstract: A nucleic acid constructs are used in improving site-specific insertion of an exogenous nucleic acid into a genome. In some aspects the nucleic acid construct having a first polynucleotide sequence encoding a DNA binding protein engineered to bind to a specific genomic DNA sequence, a second polynucleotide having a modified integrase or a modified transposase that enables insertion of exogenous nucleic acid into the genome, and a nucleic acid sequence encoding a linker between the two nucleotides. In some aspects, the nucleic acid construct encodes a fusion protein, for example, a fusion protein for delivery to a cell by a lentiviral particle.
    Type: Application
    Filed: June 11, 2020
    Publication date: July 28, 2022
    Applicant: UNIVERSITAT POMPEU FABRA
    Inventors: Avencia SÁNCHEZ-MEJÍAS GARCÍA, Marc GÜELL CARGOL, Dimitrie IVANCIC DJERMANOVIC, Maria PALLARÈS MASMITJA
  • Publication number: 20220235382
    Abstract: Methods are provided for altering target DNA in a cell genetically modified to express a Cas 9 enzyme that forms a co-localization complex with a guide RNA complementary to the target DNA and that cleaves the target DNA in a site specific manner Methods include introducing into the cell a first foreign nucleic acid encoding a donor nucleic acid sequence, introducing into the cell from media surrounding the cell the guide RNA complementary to the target DNA and which guides the Cas 9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, wherein the donor nucleic acid sequence is expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the cell.
    Type: Application
    Filed: April 7, 2022
    Publication date: July 28, 2022
    Inventors: George M. Church, Luhan Yang, Marc Guell, Joyce Lichi Yang
  • Patent number: 11306328
    Abstract: Methods are provided for altering target DNA in a cell genetically modified to express a Cas 9 enzyme that forms a co-localization complex with a guide RNA complementary to the target DNA and that cleaves the target DNA in a site specific manner. Methods include introducing into the cell a first foreign nucleic acid encoding a donor nucleic acid sequence, introducing into the cell from media surrounding the cell the guide RNA complementary to the target DNA and which guides the Cas 9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, wherein the donor nucleic acid sequence is expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the cell.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: April 19, 2022
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell, Joyce Lichi Yang
  • Patent number: 11064684
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Grant
    Filed: August 5, 2019
    Date of Patent: July 20, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Publication number: 20210187043
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: October 19, 2017
    Publication date: June 24, 2021
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20210100225
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Application
    Filed: December 11, 2020
    Publication date: April 8, 2021
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Patent number: 10959413
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Grant
    Filed: October 7, 2016
    Date of Patent: March 30, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Patent number: 10925263
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Grant
    Filed: December 10, 2019
    Date of Patent: February 23, 2021
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Publication number: 20200392452
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: August 28, 2020
    Publication date: December 17, 2020
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Patent number: 10774305
    Abstract: Aspects of the invention relate to compositions comprising one or more live bacterial strains for topical administration to the skin, wherein the one or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Grant
    Filed: April 20, 2016
    Date of Patent: September 15, 2020
    Assignee: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Publication number: 20200170229
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Application
    Filed: December 10, 2019
    Publication date: June 4, 2020
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Patent number: 10563225
    Abstract: Methods are provided for the use of Cas9 in genome engineering of stem cells. Methods include introducing into the stem cell a first foreign nucleic acid encoding a guide RNA complementary to a target DNA and which guides a Cas9 enzyme to the target DNA, wherein the RNA and the enzyme are members of a co-localization complex for the target DNA, introducing into the stem cell a second foreign nucleic acid encoding a donor nucleic acid sequence, wherein the guide RNA and the donor nucleic acid sequences are expressed, wherein the guide RNA and the Cas 9 enzyme co-localize to the target DNA, the Cas 9 enzyme cleaves the target DNA and the donor nucleic acid is inserted into the target DNA to produce altered DNA in the stem cell.
    Type: Grant
    Filed: June 30, 2014
    Date of Patent: February 18, 2020
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell, Joyce Lichi Yang
  • Publication number: 20190350177
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Application
    Filed: August 5, 2019
    Publication date: November 21, 2019
    Applicant: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell
  • Publication number: 20190314428
    Abstract: Aspects of the invention relate to compositions comprising two or more live bacterial strains for topical administration to the skin, wherein the two or more live bacterial strains are Propionibacterium acnes (P. acnes) bacterial strains, and methods for use.
    Type: Application
    Filed: October 19, 2017
    Publication date: October 17, 2019
    Applicant: S-Biomedic NV
    Inventors: Bernhard Pätzold, Marc Güell
  • Patent number: 10375938
    Abstract: A method of modulating some or all copies of a gene in a cell is provided including introducing into a cell one or more ribonucleic acid (RNA) sequences that comprise a portion that is complementary to all or a portion of each of the one or more target nucleic acid sequences, and a nucleic acid sequence that encodes a Cas protein and maintaining the cells under conditions in which the Cas protein is expressed and the Cas protein binds and modulates the one or more target nucleic acid sequences in the cell.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: August 13, 2019
    Assignee: President and Fellows of Harvard College
    Inventors: George M. Church, Luhan Yang, Marc Guell